R1 RCM Inc. (RCM)
USD 14.31
(N/A%)
USD 14.31
(N/A%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 336.6 Million USD | 25.86% |
| 2022 | 174.8 Million USD | 45.67% |
| 2021 | 120 Million USD | 17.19% |
| 2020 | 102.4 Million USD | -1.92% |
| 2019 | 104.4 Million USD | -18.63% |
| 2018 | 128.3 Million USD | 110.33% |
| 2017 | 61 Million USD | -35.76% |
| 2016 | 94.95 Million USD | 26.67% |
| 2015 | 74.96 Million USD | 7.27% |
| 2014 | 69.88 Million USD | -12.59% |
| 2013 | 79.95 Million USD | 18.01% |
| 2012 | 67.75 Million USD | -54.15% |
| 2011 | 147.77 Million USD | 39.8% |
| 2010 | 105.7 Million USD | 29.03% |
| 2009 | 81.91 Million USD | 35.49% |
| 2008 | 60.46 Million USD | 38.9% |
| 2007 | 43.52 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 95.5 Million USD | 65.8% |
| 2024 Q1 | 64.4 Million USD | 15.62% |
| 2024 Q2 | 57.6 Million USD | -10.56% |
| 2023 Q4 | 55.7 Million USD | -33.77% |
| 2023 Q1 | 77.2 Million USD | 42.44% |
| 2023 Q3 | 84.1 Million USD | -7.48% |
| 2023 Q2 | 90.9 Million USD | 17.75% |
| 2023 FY | 220 Million USD | 25.86% |
| 2022 Q3 | 60.8 Million USD | 96.76% |
| 2022 FY | 174.8 Million USD | 45.67% |
| 2022 Q4 | 54.2 Million USD | -10.86% |
| 2022 Q1 | 28.9 Million USD | -34.47% |
| 2022 Q2 | 30.9 Million USD | 6.92% |
| 2021 Q1 | 25.6 Million USD | -51.52% |
| 2021 Q2 | 29 Million USD | 13.28% |
| 2021 Q3 | 33.2 Million USD | 14.48% |
| 2021 Q4 | 44.1 Million USD | 32.83% |
| 2021 FY | 120 Million USD | 17.19% |
| 2020 Q3 | 41.4 Million USD | 0.24% |
| 2020 FY | 102.4 Million USD | -1.92% |
| 2020 Q1 | 25.5 Million USD | -31.27% |
| 2020 Q2 | 41.3 Million USD | 61.96% |
| 2020 Q4 | 52.8 Million USD | 27.54% |
| 2019 FY | 104.4 Million USD | -18.63% |
| 2019 Q1 | 22.5 Million USD | -38.02% |
| 2019 Q3 | 28.3 Million USD | 9.69% |
| 2019 Q2 | 25.8 Million USD | 14.67% |
| 2019 Q4 | 37.1 Million USD | 31.1% |
| 2018 Q3 | 29.6 Million USD | 31.56% |
| 2018 Q2 | 22.5 Million USD | 15.98% |
| 2018 FY | 128.3 Million USD | 110.33% |
| 2018 Q1 | 19.4 Million USD | 15.48% |
| 2018 Q4 | 36.3 Million USD | 22.64% |
| 2017 Q3 | 15.1 Million USD | 23.77% |
| 2017 Q1 | 14.3 Million USD | -13.69% |
| 2017 FY | 61 Million USD | -35.76% |
| 2017 Q4 | 16.8 Million USD | 11.26% |
| 2017 Q2 | 12.2 Million USD | -14.69% |
| 2016 Q3 | 16.2 Million USD | -34.3% |
| 2016 Q4 | 16.56 Million USD | 2.27% |
| 2016 Q1 | 17.53 Million USD | 15.09% |
| 2016 FY | 94.95 Million USD | 26.67% |
| 2016 Q2 | 24.66 Million USD | 40.63% |
| 2015 Q1 | 17.36 Million USD | 6.69% |
| 2015 Q4 | 15.23 Million USD | -28.78% |
| 2015 Q3 | 21.39 Million USD | 2.03% |
| 2015 Q2 | 20.96 Million USD | 20.78% |
| 2015 FY | 74.96 Million USD | 7.27% |
| 2014 Q4 | 16.27 Million USD | -3.04% |
| 2014 Q3 | 16.78 Million USD | -13.74% |
| 2014 Q2 | 19.45 Million USD | 12.05% |
| 2014 Q1 | 17.36 Million USD | 4.26% |
| 2014 FY | 69.88 Million USD | -12.59% |
| 2013 Q1 | 22.05 Million USD | 136.16% |
| 2013 FY | 79.95 Million USD | 18.01% |
| 2013 Q3 | 22.56 Million USD | 20.81% |
| 2013 Q4 | 16.65 Million USD | -26.17% |
| 2013 Q2 | 18.67 Million USD | -15.33% |
| 2012 Q2 | 46.62 Million USD | 10.05% |
| 2012 Q3 | 39.75 Million USD | -14.73% |
| 2012 Q1 | 42.36 Million USD | -2.4% |
| 2012 Q4 | -60.99 Million USD | -253.42% |
| 2012 FY | 67.75 Million USD | -54.15% |
| 2011 Q3 | 36.76 Million USD | 8.69% |
| 2011 Q4 | 43.4 Million USD | 18.05% |
| 2011 Q1 | 33.77 Million USD | 16.07% |
| 2011 FY | 147.77 Million USD | 39.8% |
| 2011 Q2 | 33.82 Million USD | 0.17% |
| 2010 FY | 105.7 Million USD | 29.03% |
| 2010 Q2 | 26.45 Million USD | 17.71% |
| 2010 Q4 | 29.09 Million USD | 5.15% |
| 2010 Q3 | 27.67 Million USD | 4.59% |
| 2010 Q1 | 22.47 Million USD | 9.73% |
| 2009 FY | 81.91 Million USD | 35.49% |
| 2009 Q2 | 19.79 Million USD | -0.97% |
| 2009 Q3 | 21.64 Million USD | 9.31% |
| 2009 Q4 | 20.48 Million USD | -5.36% |
| 2009 Q1 | 19.99 Million USD | 10.67% |
| 2008 Q3 | 14.81 Million USD | 0.0% |
| 2008 Q4 | 18.06 Million USD | 21.93% |
| 2008 FY | 60.46 Million USD | 38.9% |
| 2007 FY | 43.52 Million USD | 0.0% |
| 2000 Q4 | 537 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Accolade, Inc. | 306.51 Million USD | -9.816% |
| Aclarion, Inc. | 4.87 Million USD | -6803.685% |
| Aclarion, Inc. | 4.87 Million USD | -6803.685% |
| Augmedix, Inc. | 40.3 Million USD | -735.132% |
| HeartBeam, Inc. | 15.31 Million USD | -2097.989% |
| HeartBeam, Inc. | 15.31 Million USD | -2097.989% |
| Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -6101.951% |
| BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 73.838% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 73.838% |
| CareCloud, Inc. | 93.35 Million USD | -260.551% |
| CareCloud, Inc. | 93.35 Million USD | -260.551% |
| Certara, Inc. | 254.08 Million USD | -32.473% |
| CareMax, Inc. | 670.05 Million USD | 49.765% |
| Definitive Healthcare Corp. | 546.47 Million USD | 38.405% |
| EUDA Health Holdings Limited | 4.8 Million USD | -6907.932% |
| GE HealthCare Technologies Inc. | 5.48 Billion USD | 93.866% |
| Health Catalyst, Inc. | 258.73 Million USD | -30.097% |
| Healthcare Triangle, Inc. | 18.12 Million USD | -1757.103% |
| MSP Recovery, Inc. | 565.43 Million USD | 40.47% |
| Mangoceuticals, Inc. | 9.65 Million USD | -3387.942% |
| National Research Corporation | 52.52 Million USD | -540.899% |
| Nutex Health, Inc. | 66.54 Million USD | -405.801% |
| OptimizeRx Corporation | 69.3 Million USD | -385.703% |
| Renalytix Plc | 29.04 Million USD | -1059.051% |
| Sharecare, Inc. | 225.97 Million USD | -48.955% |
| Sharecare, Inc. | 225.97 Million USD | -48.955% |
| SHL Telemedicine Ltd. | 34.26 Million USD | -882.286% |
| Spok Holdings, Inc. | 90.97 Million USD | -269.975% |
| Streamline Health Solutions, Inc. | 31.19 Million USD | -979.192% |
| TruBridge, Inc. | 206.17 Million USD | -63.263% |
| 10x Genomics, Inc. | 674.94 Million USD | 50.13% |
| Zhongchao Inc. | 13.92 Million USD | -2317.673% |